T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
SL Green Realty
SLG
$4.5B
| $18.7M | ﹤0.01% |
553,849
-339,102
| -38% | -$11.4M |
|
927
Nordson
NDSN
$12.8B
| $18.7M | ﹤0.01% |
78,506
+564
| +0.7% | +$134K |
|
928
Rollins
ROL
$28.2B
| $18.6M | ﹤0.01% |
508,461
+11,731
| +2% | +$429K |
|
929
Sapiens International
SPNS
$2.4B
| $18.6M | ﹤0.01% |
1,004,031
-38,110
| -4% | -$704K |
|
930
Garmin
GRMN
$46.4B
| $18.4M | ﹤0.01% |
199,841
+1,733
| +0.9% | +$160K |
|
931
Constellium
CSTM
$2.09B
| $18.3M | ﹤0.01% |
1,548,638
-66,091
| -4% | -$782K |
|
932
Biohaven
BHVN
$1.49B
| $18.3M | ﹤0.01% |
+1,316,204
| New | +$18.3M |
|
933
Amicus Therapeutics
FOLD
$2.47B
| $18.2M | ﹤0.01% |
1,490,195
+31,475
| +2% | +$384K |
|
934
Supernus Pharmaceuticals
SUPN
$2.62B
| $18.2M | ﹤0.01% |
509,353
+1,490
| +0.3% | +$53.1K |
|
935
Alliant Energy
LNT
$16.6B
| $18.1M | ﹤0.01% |
328,058
+1,248
| +0.4% | +$68.9K |
|
936
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3B
| $18.1M | ﹤0.01% |
+278,700
| New | +$18.1M |
|
937
CarMax
KMX
$9.19B
| $18M | ﹤0.01% |
295,346
-6,185
| -2% | -$377K |
|
938
Williams-Sonoma
WSM
$24.8B
| $17.8M | ﹤0.01% |
310,172
-5,006
| -2% | -$288K |
|
939
A10 Networks
ATEN
$1.29B
| $17.7M | ﹤0.01% |
1,066,973
+11,959
| +1% | +$199K |
|
940
Catalyst Pharmaceutical
CPRX
$2.48B
| $17.7M | ﹤0.01% |
950,774
+935,316
| +6,051% | +$17.4M |
|
941
Immuneering
IMRX
$341M
| $17.6M | ﹤0.01% |
3,619,560
-43,932
| -1% | -$213K |
|
942
Akamai
AKAM
$11.4B
| $17.5M | ﹤0.01% |
207,495
-489
| -0.2% | -$41.2K |
|
|
CINC
943
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $17.5M | ﹤0.01% |
1,423,124
+145,745
| +11% | +$1.79M |
|
944
Teradata
TDC
$2.04B
| $17.4M | ﹤0.01% |
515,620
+6,820
| +1% | +$230K |
|
945
Healthpeak Properties
DOC
$12.6B
| $17.4M | ﹤0.01% |
692,201
+2,973
| +0.4% | +$74.5K |
|
|
PWSC
946
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $17.3M | ﹤0.01% |
+751,511
| New | +$17.3M |
|
947
C4 Therapeutics
CCCC
$194M
| $17.3M | ﹤0.01% |
2,925,253
-38,803
| -1% | -$229K |
|
948
Twist Bioscience
TWST
$1.55B
| $17.2M | ﹤0.01% |
724,252
-86,971
| -11% | -$2.07M |
|
949
Bloomin' Brands
BLMN
$589M
| $17.2M | ﹤0.01% |
856,442
+72,010
| +9% | +$1.45M |
|
950
Virtus Investment Partners
VRTS
$1.36B
| $17.1M | ﹤0.01% |
89,082
-4,591
| -5% | -$879K |
|